Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-05-06

Clinical Trial Update: Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea Pedis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating clinical equivalence of two generic butenafine hydrochloride 1% creams compared with Lotrimin Ultra Cream for interdigital tinea pedis;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butenafine hydrochloride 1% Cream (generic) (Butenafine hydrochloride)
  • Lotrimin Ultra Cream (Butenafine hydrochloride)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Interdigital Tinea Pedis | Phase 1 | Status: TERMINATED